
Organobalance GmbH specializes in microbial screening and assay development, and will complement Novozymes’ existing platform with applications across industries. Bagsvaerd, Denmark, 16-Sep-2016 — /EuropaWire/ — Novozymes today announces the acquisition of microbial research company Organobalance GmbH for an undisclosed amount. Germany-based Organobalance … Read the full press release